Evidence map›Paper›PMID 26426785›Full record

GuidelineAmerican journal of respiratory and critical care medicine2015

An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice.

Renda Soylemez Wiener, Michael K Gould, Douglas A Arenberg, David H Au, Kathleen Fennig, Carla R Lamb, Peter J Mazzone, David E Midthun, Maryann Napoli, David E Ost and 8 more

Abstract readPractice Guideline
In one paragraph

Guideline in American journal of respiratory and critical care medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Prognostic role of CRABP2 in lung cancer: a meta-analysis.Journal of cardiothoracic surgery · 2024
    Pooled it
  2. Pooled it
  3. Guideline
  4. Guideline
  5. Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.Journal of the National Comprehensive Cancer Network : JNCCN · 2018
    Guideline
  6. Guideline
  7. Trial
  8. Trial
  9. Geographic Access to Low-Dose CT Lung Cancer Screening in Tennessee: Disparities by Socioeconomic Variables, Rurality, and Appalachian Status.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Current Evidence for a Lung Cancer Screening Program.Portuguese journal of public health · 2024
    Review
  18. Observational
  19. Article
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Renda Soylemez Wiener
Michael K Gould
Douglas A Arenberg
David H Au
Kathleen Fennig
Carla R Lamb
Peter J Mazzone
David E Midthun
Maryann Napoli
David E Ost
Charles A Powell
M Patricia Rivera
Christopher G Slatore
Nichole T Tanner
Anil Vachani
Juan P Wisnivesky
Sue H Yoon
ATS/ACCP Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice

Funding

Lung Adenocarcinoma Invasion GenomicsR01CA163772 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MASSION, PIERRE P., POWELL, CHARLES A. · 2013 to 2017
$2.9M
NCI NIH HHS K07 CA138722NCI NIH HHS R01 CA163772
6 · The paper itself

Abstract

rationaleAnnual low-radiation-dose computed tomography (LDCT) screening for lung cancer has been shown to reduce lung cancer mortality among high-risk individuals and is now recommended by multiple organizations. However, LDCT screening is complex, and implementation requires careful planning to ensure benefits outweigh harms. Little guidance has been provided for sites wishing to develop and implement lung cancer screening programs.

objectivesTo promote successful implementation of comprehensive LDCT screening programs that are safe, effective, and sustainable.

methodsThe American Thoracic Society (ATS) and American College of Chest Physicians (ACCP) convened a committee with expertise in lung cancer screening, pulmonary nodule evaluation, and implementation science. The committee reviewed the evidence from systematic reviews, clinical practice guidelines, surveys, and the experience of early-adopting LDCT screening programs and summarized potential strategies to implement LDCT screening programs successfully. MEASUREMENTS AND MAIN

resultsWe address steps that sites should consider during the main three phases of developing an LDCT screening program: planning, implementation, and maintenance. We present multiple strategies to implement the nine core elements of comprehensive lung cancer screening programs enumerated in a recent ACCP/ATS statement, which will allow sites to select the strategy that best fits with their local context and workflow patterns. Although we do not comment on cost-effectiveness of LDCT screening, we outline the necessary costs associated with starting and sustaining a high-quality LDCT screening program.

conclusionsFollowing the strategies delineated in this policy statement may help sites to develop comprehensive LDCT screening programs that are safe and effective.

Indexed as

HumansLung NeoplasmsMass ScreeningRadiation DosageRadiography, ThoracicSmoking CessationSocieties, MedicalSolitary Pulmonary NoduleTomography, X-Ray ComputedUnited States

Identifiers

PMID26426785
PMCPMC4613898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.